scPharmaceuticals Inc (SCPH) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

false 0001604950 0001604950 2023-06-06 2023-06-06     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Current Report Filing (8-k)

false 0001604950 0001604950 2023-06-07 2023-06-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Current Report Filing (8-k)

false 0001604950 0001604950 2023-05-10 2023-05-10     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Additional Proxy Soliciting Materials (definitive) (defa14a)

f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...

Proxy Statement (definitive) (def 14a)

f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A...